Humans carry genes that predispose us to atherosclerosis, the disease that causes heart attacks, because those same genes may have once helped our ancestors survive and reproduce. That's the ...
Miami-based Baptist Health Heart & Vascular Care at Baptist Health Miami Cardiac & Vascular Institute has added Sheng Fu, MD. Dr. Fu is an advanced heart failure and transplant cardiologist, ...
Some bacterial species, particularly some linked to inflammation, are associated with coronary artery disease, a common form ...
With a snip of a gene, doctors may one day permanently lower dangerously high cholesterol, possibly removing the need for ...
We’re taking a closer look at the STS Awards, what they represent, and why they matter. Dr. Sabet Hashim, co-physician in chief at the Hartford HealthCare ...
Presentation of MyPEAK-1 Data and the American Heart Association Scientific Sessions Showed Consistent, Deeper, and Durable ...
11hon MSN
Triglyceride-lowering drug significantly reduce rate of acute pancreatitis in high-risk patients
Researchers from Mass General Brigham have found that olezarsen—a drug designed to lower triglyceride levels—can also ...
News-Medical.Net on MSN
One-time CRISPR therapy safely lowers cholesterol and triglycerides in early trial
In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL ...
From revolutionary CRISPR treatment to heavy drinking dangers, here's what you need to know about the latest health research.
News-Medical.Net on MSN
Triglyceride-lowering drug can also decrease the risk of acute pancreatitis
Researchers from Mass General Brigham have found that olezarsen-a drug designed to lower triglyceride levels-can also ...
Managing hypertension may lower dementia risk A new 2025 high blood pressure guideline from the American Heart Association (AHA) and the American College of Cardiology (ACC) calls for earlier ...
10hon MSN
First-in-human trial of CRISPR gene-editing therapy safely lowers cholesterol and triglycerides
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results